Small capRs 1,782 crRs 1.4 cr traded a dayThin: a ₹2 lakh order is 1.4% of a normal day
Close on 10 September 2026
612.50
−1.78%
52-week range35% of the way up
528.40772.10
Market cap
1,782 cr
P/E (TTM)
14.2×
EPS (TTM)
43.02
Revenue YoY
-11.5%
Q1 FY27
Profit YoY
-24.5%
Net margin
7.2%
-1.2pt vs a year ago
Growth trend
-30.3pt
vs last quarter’s YoY
1 month
-2.6%
Below 52w high
26.1%
RSI (14)
51
Daily swing
3.9%
average true range
Volume
0.3×
vs 20-day average
Traded
Rs 1 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Below the median
-6.5%
One-year return
Below the median
-21.6%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
-11.5%
Below the 52-week high
from the highest close of the year
-20.7%
1 week
−0.27%
1 month
−2.56%
3 months
−13.71%
6 months
+5.49%
1 year
−21.62%
The read
written from the numbers on this page
The evidence leans negative0 supporting, 5 against, 0 worth knowing
Supporting
nothing the data supports either way
Against
trading 7% below its 200-day average
down 22% over twelve months
1 of the scans it matches has historically underperformed the market
revenue fell 12% year on year in the quarter ending 30 June 2026
net margin has narrowed from 9.3% to 7.2% across four quarters
Worth knowing
nothing the data supports either way
What would change this read: a close back above 655, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working
Nothing on this side tonight — not in the filings and not in the price.
Needs watching6
Profit fell year on year in all 4 of the last 4 quarters.
4
Net profit -24.5% year on year, Rs 58 cr to Rs 44 cr.
-24.5%Rs 58 crRs 44 cr
Revenue -11.5% year on year, Rs 691 cr to Rs 612 cr.
-11.5%Rs 691 crRs 612 cr
Trading 6.5% below its 200-day average.
-6.5%
Down 21.6% over the past year.
-21.6%
Only Rs 1.4 crore changes hands on a median day. A large order moves this price by itself.
Rs 1.4 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 1 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
1 of 47 matched on 10 Sep
INSECTICID matches 1 of the 47 scans today, across 1 different kinds of evidence.
INSECTICID trades at 14× trailing earnings, close to its median of 14× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Analyst call filings were typically +0.11pt vs the market over the next 5 sessions (n=4,339) · AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
net margin widened from 2.7% to 7.2%
Going against it
revenue fell 12% against the same quarter a year earlier
profit dropped 24% year on year
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
612
59
44
15.08
7.2%
Q4 FY26
31 Mar · consolidated
426
17
12
4.02
2.7%
Q3 FY26
31 Dec · consolidated
385
14
10
3.60
2.7%
Q2 FY26
30 Sep · consolidated
638
79
59
20.31
9.3%
Q1 FY26
30 Jun · consolidated
691
77
58
19.97
8.4%
Q4 FY25
31 Mar · consolidated
359
22
14
4.77
3.9%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-2.5%
Versus 200-day average-6.5%
Below 52-week high-20.7%
Above 52-week low+15.9%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)50.9
Higher closes in last 53 of 5
Six-month return+5.49%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.